OncoSil

OSL.AX

Tags: AU Healthcare Medical - Devices

OncoSil Medical Limited Price (OSL.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

2,219,392,243

(85.5617)%

Market Cap of OncoSil (OSL.AX)

Market cap:

As of , OSL.AX has a market cap of . This makes OSL.AX the 1061th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorpora... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.004-0.015
Market Cap 18.43M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Devices

ceo: Mr. Nigel Lange
IPO Date: August, 15, 2005
Country: AU
Currency: AUD
Headquaters: North Sydney, NSW
Employees: 2

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: